News >

EBV DNA Screening Detects Early Asymptomatic Nasopharyngeal Carcinoma

Jason Harris
Published: Monday, Aug 14, 2017

KC Allen Chan, MBBS

KC Allen Chan, MBBS
Hong Kong researchers were able to detect nasopharyngeal carcinoma significantly earlier by screening for circulating cell-free Epstein-Barr virus (EBV) DNA, according to results recently published in the New England Journal of Medicine.

In participants with positive results, investigators collected another blood sample approximately 4 weeks later.
Chan KCA, Woo JKS, King A, et al. Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer. N Engl J Med. 2017;377(6):513-522. doi: 10.1056/NEJMoa1701717.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
Publication Bottom Border
Border Publication
x